首页> 外文期刊>Biotechnology Progress >An Ultra Scale-Down Approach to Assess the Impact of the Choice of Recombinant P. pastoris Strain on Dewatering Performance in Centrifuges
【24h】

An Ultra Scale-Down Approach to Assess the Impact of the Choice of Recombinant P. pastoris Strain on Dewatering Performance in Centrifuges

机译:一种超规模化方法,评估重组巴斯德毕赤酵母菌株选择对离心机脱水性能的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Pichia pastoris is becoming a desirable host in the biopharmaceutical industry for therapeutics production. It grows on methanol to high cell densities >100 g DCW/L and secretes foreign proteins at high titers. However, the culture conditions to reach high cell densities pose a challenge to the processability by primary recovery operations, in particular centrifu-gation, used for cell removal. This work aims to assess the impact of recombinant P. pastoris strain selection on centrifugal dewatering. Normally, the choice of P. pastoris recombinant strain is based on best target protein expression levels;;however, it is unknown whether the choice of strain will have an impact on performance of centrifugation operation. To achieve this aim, a previously developed laboratory ultra-scale down (USD) methodology that successfully predicted centrifugal dewatering of pilot-scale disk-type machines, was used in this work. Two recombinant P. pastoris strains, namely a X-33 and a glycoengi-neered Pichia strain, were used to perform fermentations secreting different products. The resulting harvested fermentation culture properties were analyzed and the dewatering performances of a pilot- and a large-scale disk-type centrifuge were evaluated using the USD methodology. The choice of P. pastoris strain was found to have a considerable impact on dewatering performance, with P. pastoris X-33 strain reaching better dewatering levels than the glycoengineered strain. The USD method proved to be a useful tool to determine optimal conditions under which the large scale centrifuge needed to be operated, reducing the need for repeated pilot-scale runs during early stages of process development for therapeutic products.
机译:巴斯德毕赤酵母正成为生物制药工业中用于治疗药物生产的理想宿主。它可以在甲醇中生长到> 100 g DCW / L的高细胞密度,并以高滴度分泌外源蛋白质。然而,达到高细胞密度的培养条件通过用于细胞去除的主要回收操作,特别是离心分离,对可加工性提出了挑战。这项工作旨在评估重组巴斯德毕赤酵母菌株选择对离心脱水的影响。通常,巴斯德毕赤酵母重组菌株的选择基于最佳靶蛋白表达水平;但是,尚不清楚菌株的选择是否会影响离心操作的性能。为了实现这一目标,这项工作中使用了以前开发的实验室超规模降级(USD)方法,该方法成功地预测了中试规模盘式机器的离心脱水。两种重组巴斯德毕赤酵母菌株,即X-33和甘氨酸针状毕赤酵母菌株,用于进行分泌不同产物的发酵。分析所得收获的发酵培养物的性质,并使用USD方法评估中试和大型圆盘式离心机的脱水性能。发现巴斯德毕赤酵母菌株的选择对脱水性能具有相当大的影响,其中毕赤酵母X-33菌株达到比糖工程菌株更好的脱水水平。 USD方法被证明是确定大型离心机需要操作的最佳条件的有用工具,从而减少了在治疗产品开发过程的早期阶段重复进行中试规模的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号